These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6131490)

  • 1. Type I tardive dyskinesia induced by anticholinergic drugs, dopamine agonists and neuroleptics.
    Chouinard G; Steinberg S
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):571-8. PubMed ID: 6131490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dyskinesia and anticholinergic drugs.
    Gardos G; Cole JO
    Am J Psychiatry; 1983 Feb; 140(2):200-2. PubMed ID: 6129809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on tardive dyskinesia.
    Simpson GM; Pi EH; Sramek JJ
    Hosp Community Psychiatry; 1986 Apr; 37(4):362-9. PubMed ID: 2870977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug therapy of tardive dyskinesia.
    Kobayashi RM
    N Engl J Med; 1977 Feb; 296(5):257-60. PubMed ID: 12469
    [No Abstract]   [Full Text] [Related]  

  • 5. Current psychopathological theories of tardive dyskinesia and their implications for future research.
    Ananth J
    Neuropsychobiology; 1982; 8(4):210-22. PubMed ID: 6127649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Swallowing, tardive dyskinesia and anticholinergics.
    Craig TJ; Richardson MA
    Am J Psychiatry; 1982 Aug; 139(8):1083. PubMed ID: 6124138
    [No Abstract]   [Full Text] [Related]  

  • 7. Classification of neuroleptics: implications for tardive dyskinesia.
    Christensen AV
    Pol J Pharmacol Pharm; 1985; 37(3):295-309. PubMed ID: 2866499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic-induced supersensitivity psychosis in patients with bipolar affective disorder.
    Steiner W; Laporta M; Chouinard G
    Acta Psychiatr Scand; 1990 May; 81(5):437-40. PubMed ID: 1972608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Occurrence of tardive dyskinesia during neuroleptic treatment].
    Fanget F; Henry E; Aimard G
    Presse Med; 1986 Dec; 15(43):2147-50. PubMed ID: 2884657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity?
    Jeste DV; Wyatt RJ
    J Clin Psychiatry; 1981 Dec; 42(12):455-7. PubMed ID: 6118358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe cases of neuroleptic-induced supersensitivity psychosis. Diagnostic criteria for the disorder and its treatment.
    Chouinard G
    Schizophr Res; 1991; 5(1):21-33. PubMed ID: 1677263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent neuroleptic therapy and tardive dyskinesia: a literature review.
    Goldman MB; Luchins DJ
    Hosp Community Psychiatry; 1984 Dec; 35(12):1215-9. PubMed ID: 6150891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum.
    Boyson SJ; McGonigle P; Luthin GR; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1988 Mar; 244(3):987-93. PubMed ID: 2908050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The possible role of dopamine autoreceptors in neuroleptic atypicality.
    Javitt DC; Weinstein SL; Opler LA
    Psychiatr Dev; 1988; 6(1):57-71. PubMed ID: 2902622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic measures in tardive dyskinesia].
    Tegeler J; Wöller W
    Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
    Berger PA; Rexroth K
    Schizophr Bull; 1980; 6(1):102-16. PubMed ID: 6102788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tardive dyskinesia: a role for the endogenous opioid system.
    Sandyk R
    Med Hypotheses; 1986 Jan; 19(1):71-4. PubMed ID: 2871480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse effects of anticholinergic antiparkinsonian drugs in tardive dyskinesia. An investigation of mechanism.
    Burnett GB; Prange AJ; Wilson IC; Jolliff LA; Creese IC; Synder SH
    Neuropsychobiology; 1980; 6(2):109-20. PubMed ID: 6101910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategies against tardive dyskinesia. Two decades of experience.
    Jeste DV; Wyatt RJ
    Arch Gen Psychiatry; 1982 Jul; 39(7):803-16. PubMed ID: 6131655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dyskinesia: review and update.
    Klawans HL; Goetz CG; Perlik S
    Am J Psychiatry; 1980 Aug; 137(8):900-8. PubMed ID: 6106395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.